CT or Invasive Coronary Angiography in Stable Chest Pain.
DISCHARGE Trial Group, Pál Maurovich-Horvat, Maria Bosserdt...
https://pubmed.ncbi.nlm.nih.gov/35240010/Actively Recruiting
Led by Philipps University Marburg · Updated on 2026-04-07
3369
Participants Needed
39
Research Sites
N/A
Total Duration
Researchers are investigating a new nationwide care model called NVF to improve the diagnosis and treatment of patients with recent-onset stable chest pain and suspected coronary artery disease CAD in Germany. This study aims to enhance the use of coronary computed tomography CT as an alternative to cardiac catheterisation, potentially reducing cardiovascular events like heart attacks and strokes while lowering healthcare costs. The trial is a pragmatic, cluster-randomised stepped-wedge design conducted in 16 regions across Germany. Participants will be assigned to one of two groups usual care following national guidelines without structured coordination, or the IMPRO cross-sectoral care model that connects general practitioners with certified cardiac CT centres. The IMPRO program includes evidence-based initial assessments, shared decision-making among doctors and patients, quality-assured CT imaging, structured reporting, and ongoing training and quality monitoring at participating sites. This intervention is designed to improve diagnostic accuracy and care coordination. During the study, participants will be monitored for major adverse cardiovascular events MACE such as cardiovascular death, myocardial infarction, or stroke over 12 months, with extended follow-up up to 5 years. Researchers will also track procedure-related complications, test rates, hospitalizations, emergency visits, radiation exposure, quality of life, angina symptoms, and medical costs. Data collection includes baseline and follow-up assessments at 3 months, 12 months, and 5 years to evaluate clinical outcomes, safety, cost-effectiveness, and patient quality of life.
CONDITIONS
Improved Management of Patients With Recent-Onset Stable Chest Pain
A
Annika Viniol, Prof. Dr.
M
Marc Dewey, Prof. Dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Philipps University Marburg
Lead Sponsor
Gemeinsamer Bundesaussschuss
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From enrollment to 12 months
Participants undergo diagnostic assessment using either usual care or the IMPRO cross-sectoral care model for suspected coronary artery disease, which includes coordinated imaging diagnostics such as coronary CT.
Visits as part of usual care or IMPRO program follow-up
Duration - Up to 5 years after enrollment
Participants are monitored for major adverse cardiovascular events and other health outcomes to evaluate the effectiveness of the care model over time.
Follow-up visits at 3 months, 12 months, and 5 years
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
DISCHARGE Trial Group, Pál Maurovich-Horvat, Maria Bosserdt...
https://pubmed.ncbi.nlm.nih.gov/35240010/Marc Dewey, Matthias Rief, Peter Martus...
https://pubmed.ncbi.nlm.nih.gov/27777234/Jutta Jung-Henrich, Kathrin Schlößler, Til Uebel...
https://pubmed.ncbi.nlm.nih.gov/38664649/Philipps University Marburg
Lead Sponsor
Gemeinsamer Bundesaussschuss
Collaborating Sponsor